Petros Pharmaceuticals, Inc. Prepaid Expense and Other Assets
Petros Pharmaceuticals, Inc. (PTPI) had Prepaid Expense and Other Assets of $63.20 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Assets
us-gaap:PrepaidExpenseAndOtherAssets · last filed 2025-11-13
- 2025-09-30: Prepaid Expense and Other Assets $63.20K.
- 2025-06-30: Prepaid Expense and Other Assets $75.34K.
- 2025-03-31: Prepaid Expense and Other Assets $53.41K.
- 2024-12-31: Prepaid Expense and Other Assets $885.00; Prepaid Expense and Other Assets as first filed $169.22K.
| Period end | Prepaid Expense and Other Assets | Prepaid Expense and Other Assets as first filed |
|---|---|---|
| 2025-09-30 | $63.20K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $75.34K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $53.41K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $885.00 10-Q · filed 2025-11-13 | $169.22K 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.83M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.89M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.12M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.03M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $987.12K 10-Q · filed 2023-11-15 | |
| 2023-06-30 | $1.01M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.15M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.32M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $1.70M 10-Q/A · filed 2022-11-15 | |
| 2022-06-30 | $1.90M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $3.48M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $3.72M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $2.75M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.74M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $2.64M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $2.85M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |